These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 23530689)

  • 1. Actigraphic assessment of periodic leg movements in patients with restless legs syndrome.
    Cippà MA; Baumann CR; Siccoli MM; Bassetti CL; Poryazova R; Werth E
    J Sleep Res; 2013 Oct; 22(5):589-92. PubMed ID: 23530689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial.
    Dauvilliers Y; Benes H; Partinen M; Rauta V; Rifkin D; Dohin E; Goldammer N; Schollmayer E; Schröder H; Winkelman JW
    Am J Kidney Dis; 2016 Sep; 68(3):434-43. PubMed ID: 26851201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless leg syndrome is a treatable cause of sleep disturbance and fatigue in primary biliary cirrhosis.
    Anderson K; Jones DE; Wilton K; Newton JL
    Liver Int; 2013 Feb; 33(2):239-43. PubMed ID: 23295055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of the PAM-RL device for evaluating periodic limb movements in sleep and an investigation on night-to-night variability of periodic limb movements during sleep in patients with restless legs syndrome or periodic limb movement disorder using this system.
    Kobayashi M; Namba K; Ito E; Nishida S; Nakamura M; Ueki Y; Furudate N; Kagimura T; Usui A; Inoue Y
    Sleep Med; 2014 Jan; 15(1):138-43. PubMed ID: 24269130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Periodic Limb Movements During Sleep in Restless Legs Syndrome: A Selective Update.
    Fulda S
    Sleep Med Clin; 2015 Sep; 10(3):241-8, xii. PubMed ID: 26329434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Night-to-night variability of periodic leg movements during sleep in restless legs syndrome and periodic limb movement disorder: comparison between the periodicity index and the PLMS index.
    Ferri R; Fulda S; Manconi M; Högl B; Ehrmann L; Ferini-Strambi L; Zucconi M
    Sleep Med; 2013 Mar; 14(3):293-6. PubMed ID: 23068780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leg movements during wakefulness in restless legs syndrome: time structure and relationships with periodic leg movements during sleep.
    Ferri R; Manconi M; Plazzi G; Bruni O; Cosentino FI; Ferini-Strambi L; Zucconi M
    Sleep Med; 2012 May; 13(5):529-35. PubMed ID: 22341907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
    Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
    Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma apelin level in patients with restless legs syndrome and its association with periodic leg movements.
    Korkmaz S; Aksu M; Baskol G
    Sleep Breath; 2017 Mar; 21(1):19-24. PubMed ID: 27193873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
    Nomura T; Inoue Y; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post Hoc Analysis of Data from Two Clinical Trials Evaluating the Minimal Clinically Important Change in International Restless Legs Syndrome Sum Score in Patients with Restless Legs Syndrome (Willis-Ekbom Disease).
    Ondo WG; Grieger F; Moran K; Kohnen R; Roth T
    J Clin Sleep Med; 2016 Jan; 12(1):63-70. PubMed ID: 26446245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
    Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
    Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between putative indicators of primary restless legs syndrome severity.
    Aksu M; Demirci S; Bara-Jimenez W
    Sleep Med; 2007 Jan; 8(1):84-9. PubMed ID: 16740410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs symptoms without periodic limb movements in sleep and without response to dopaminergic agents: a restless legs-like syndrome?
    Baumann CR; Marti I; Bassetti CL
    Eur J Neurol; 2007 Dec; 14(12):1369-72. PubMed ID: 17970736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial.
    Bassetti CL; Bornatico F; Fuhr P; Schwander J; Kallweit U; Mathis J;
    Swiss Med Wkly; 2011; 141():w13274. PubMed ID: 22101745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
    Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
    J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.